The incidence of residual neuromuscular blockade associated with single dose of intermediate-acting neuromuscular blocking drugs

Middle East Journal of Anesthesiology

Volumn 21, Issue 4, 2012, Pages 535-542

  Kaan, Nil ^a   Kocaturk, Ozlem ^b   Kurt, Ibrahim ^a   Cicek, Halil ^c  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

^b Bartin Hospital   (Turkey)

^c Korkuteli Hospital   (Turkey)

Author keywords

Atracurium; Neuromuscular blockade; Neuromuscular monitoring; Residual paralysis; Rocuronium; Vecuronium

Indexed keywords

ANDROSTANE DERIVATIVE; ATRACURIUM BESILATE; NEUROMUSCULAR BLOCKING AGENT; ROCURONIUM; VECURONIUM;

ADULT; ARTICLE; ENDOTRACHEAL INTUBATION; FEMALE; GENERAL ANESTHESIA; HUMAN; INCIDENCE; MALE; METHODOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RISK FACTOR; SEX DIFFERENCE; TIME;

ADULT; ANDROSTANOLS; ANESTHESIA, GENERAL; ATRACURIUM; FEMALE; HUMANS; INCIDENCE; INTUBATION, INTRATRACHEAL; MALE; MIDDLE AGED; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; SEX FACTORS; TIME FACTORS; VECURONIUM BROMIDE; YOUNG ADULT;

EID: 84865815445     PISSN: 05440440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Murphy GS, Brull SJ: Residual Neuromuscular Block: Lessons Unlearned. Part I: Definitions, Incidence, and Adverse Physiologic Effects of Residual Neuromuscular Block. Anesth Analg; 2010, 111:120-8.
2. th edition. Churchil Livingston: Philadelphia, 2006, 481-572.
3. Murphy GS: Residual neuromuscular blockade: incidence, assessment, and relevance in the postoperative period. Minevra Anestesiol; 2006, 72:97-109.
4. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS: Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg; 2008, 107:130-7.
5. Murphy GS, Szokol JW, Franklin M, Marymont JH, Avram MJ, Vender JS: Postanesthesia Care unit recovery times and neuromuscular blocking drugs: a prospective study of orthopedic surgical patients randomized to receive pancuronium or rocuronium. Anesth Analg; 2004, 98:193-200.
6. Eikermann M, Groeben H, Husing J, Peters J: Accelerometry of adductor pollicis muscle predicts recovery of respiratory function from neuromuscular blockade. Anesth; 2003, 98:1333-7.
7. Eriksson LI, Satoo M, Severinghaus JW: Effect of vecuronium induced partial neuromuscular block on hipoxic ventilatory response. Anesth; 1993, 78:693-9.
8. Naguip M, Kopman AF, Ensor JE: Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis. Br J Anaesth; 2007, 98:302-16.
9. Tsai CC, Chung HS, Chen PL, Chong-Ming Y, Chen MS, Hong CL: Postoperative Residual Curarization: Clinical Observation in the Post-anesthesia Care Unit. Chang Gung Med J; 2008, 31:364-8.
10. Houghton IT, Aun CS, Oh TE: Vecuronium: an anthropometric comparison. Anaesthesia; 1992, 47:741-6.
11. Semple P, Hope DA, Clyburn P, Rodbert A: Relative potency of vecuronium in male and female patients in Britain and Australia. Br J Anaesth; 1994, 72:190-4.
12. Xue F, Liau X, Liu J: Dose-response curve and timecourse of effect of vecuronium in male and female patients. Br J Anaesth; 1998, 80:720-4.
13. Xue FS, An G, Liau X, Zou Q, Zou Q, Luo LK: The pharmacokinetics of vecuronium in male and female patients. Anesth Analg; 1998, 86:1322-7.
14. Adamus M, Gabrhelik T, Marek O: Influence of gender on the course of neuromuscular block following a single bolus dose of cisatracurium or rocuronium. European Journal of Anaesthesiology; 2008, 25:589-95.
15. Xue FS, Tong SY, Liau X, Liu JH, An G, Luo LK: Dose response and time course of effect of rocuronium in male and female anesthetized patients. Anesth Analg; 1997, 85:667-71.
16. Parker CJ, Hunter JM, Snowdon SL: Effect of age, sex and anaesthetic technique on the pharmacokinetics of atracurium. Br J Anaesth; 1992, 69:439-43.
17. Xue FS, Zhang YM, Liau X, Liu JH, An G: Influences of age and gender on dose response and time course of effect of atracurium in anesthetized adult patients. J Clin Anesth; 1999, 11:397-405.
18. Alkhazrajy W, Khorasanee AD, Russel WJ: Muscle weakness after muscle relaxants: an audit of clinical practice. Anaesth Intensive Care; 2004, 32:256-9.
19. Berg H, Roed J, Viby-Mogensen J, Mortensen CR, Engbaek J, Skovgaard LT, Krintel JJ: Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand; 1997, 41:1095-103.
20. Debaen B, Plaud B, Dilly MP, Donati F: Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesth; 2003, 98:1042-8.
21. Baillard C, Clec'h C, Catineau J, Salhi F, Gehan G, Cupa M, Samama CM: Postoperative residual neuromuscular block: a survey of management. Br J Anaesth; 2005, 95:622-6.
22. Hayes AH, Mirakhur RK, Breslin DS, Reid JE, Mccourt KC: Postoperative residual block after intermediate-acting neuromuscular blocking drugs. Anesth; 2001, 56:312-8.
23. Baurain MJ, Hoton F, Hollander AA, Cantraine FR: Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonize block produced by rocuronium, vecuronium, atracurium, and pancuronium?. Br J Anaesth; 1996, 77:496-9.
24. Kopman AF, Zank LM, Ng J, Neuman GG: Antagonism of cisatracurium and rocuronium block at a tactile train-of-four count of 2: should quantitative assessment of neuromuscular function be mandatory?. Anesth Analg; 2004, 98:102-6.
25. Khan S, Divatia JV, Sareen R: Comparison of residual neuromuscular blockade between two intermediate acting nondepolarizing neuromuscular blocking agents - rocuronium and vecuronium. Indian J Anaesth; 2006, 50:115-7.
26. Brull SJ, Naguip M, Miller RD: Residual Neuromuscular Block: Rediscovering the Obvious. Anest Analg; 2008, 107:11-4.
27. Miller RD, Ward TA: Monitoring and Pharmacologic Reversal of a Nondepolarizing Neuromuscular Blockade Should Be Routine. Anest Analg; 2010, 111:3-5.
28. Brull SJ, Murphy GS: Residual Neuromuscular Block: Lessons Unlearned. Part II: Methods to Reduce the Risk of Residual Weakness. Anesth Analg; 2010, 111:129-40.
29. Viby-Mogensen J: Postoperative residuel curarization and evidence- based anaesthesia. Br J Anaesth; 2000, 84:301-2.
30. Bevan DR, Smith C, Donati F: Postoperative neuromuscular blockade: A comparison between atracurium, vecuronium, and pancuronium. Anesthesiology; 1988, 69:272-6.
31. Murphy GS, Szokol JW, Marymont JH, Franklin M, Avram MJ, Vender JS: Residual Paralysis at the Time of Tracheal Extubation. Anesth Analg; 2005, 100:1840-5.
32. Mccaul C, Tobin E, Boylan JF, Mcshane AJ: Atracurium is associated with postoperative residual curarization. Br J Anaesth; 2002, 89:766-9.